Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred Saad

Showing results (441-450 of 1,126) with videos related to

Pageof 113
Sort By:
Clinical Genitourinary Cancer|August 29, 2017
Prognostic Index Model for Progression-Free Survival in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Plus PrednisoneCharles J Ryan, Thian Kheoh, Jinhui Li, et al.
Future Oncology (London, England)|July 6, 2026
How enzalutamide affects sex life and how taking a break from treatment affects quality of life: a plain language summary of results from the EMBARK study in people with hormone-sensitive prostate cancer and high-risk biochemical recurrenceStephen J Freedland, Ugo De Giorgi, Antti Rannikko, et al.
The New England Journal of Medicine|August 13, 2009
Denosumab in men receiving androgen-deprivation therapy for prostate cancerMatthew R Smith, Blair Egerdie, Narciso Hernández Toriz, et al.
Urologic Oncology|November 15, 2020
External beam radiation therapy improves survival in elderly metastatic prostate cancer patients with low PSALara Franziska Stolzenbach, Giuseppe Rosiello, Marina Deuker, et al.
The Oncologist|October 9, 2023
Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy and Docetaxel in Black Patients From the Randomized ARASENS TrialNeal D Shore, Maha Hussain, Fred Saad, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 29, 2022
UPDATE - Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies Summary of changesAndrea Kokorovic, Alan I So, Hosam Serag, et al.
World Journal of Urology|October 25, 2017
Radical prostatectomy or radiotherapy reduce prostate cancer mortality in elderly patients: a population-based propensity score adjusted analysisMarco Bandini, Raisa S Pompe, Michele Marchioni, et al.
BJU International|November 11, 2017
First North American validation and head-to-head comparison of four preoperative nomograms for prediction of lymph node invasion before radical prostatectomyMarco Bandini, Michele Marchioni, Raisa S Pompe, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 28, 2018
Racial disparities in lymph node dissection at radical prostatectomy: A Surveillance, Epidemiology and End Results database analysisFelix Preisser, Sebastiano Nazzani, Marco Bandini, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 29, 2022
UPDATE - Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategiesAndrea Kokorovic, Alan I So, Hosam Serag, et al.
Pageof 113

Showing results (441-450 of 1,126) with videos related to

Sort By:
Pageof 113
Clinical Genitourinary Cancer|August 29, 2017
Prognostic Index Model for Progression-Free Survival in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Plus PrednisoneCharles J Ryan, Thian Kheoh, Jinhui Li, et al.
Future Oncology (London, England)|July 6, 2026
How enzalutamide affects sex life and how taking a break from treatment affects quality of life: a plain language summary of results from the EMBARK study in people with hormone-sensitive prostate cancer and high-risk biochemical recurrenceStephen J Freedland, Ugo De Giorgi, Antti Rannikko, et al.
The New England Journal of Medicine|August 13, 2009
Denosumab in men receiving androgen-deprivation therapy for prostate cancerMatthew R Smith, Blair Egerdie, Narciso Hernández Toriz, et al.
Urologic Oncology|November 15, 2020
External beam radiation therapy improves survival in elderly metastatic prostate cancer patients with low PSALara Franziska Stolzenbach, Giuseppe Rosiello, Marina Deuker, et al.
The Oncologist|October 9, 2023
Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy and Docetaxel in Black Patients From the Randomized ARASENS TrialNeal D Shore, Maha Hussain, Fred Saad, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 29, 2022
UPDATE - Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies Summary of changesAndrea Kokorovic, Alan I So, Hosam Serag, et al.
World Journal of Urology|October 25, 2017
Radical prostatectomy or radiotherapy reduce prostate cancer mortality in elderly patients: a population-based propensity score adjusted analysisMarco Bandini, Raisa S Pompe, Michele Marchioni, et al.
BJU International|November 11, 2017
First North American validation and head-to-head comparison of four preoperative nomograms for prediction of lymph node invasion before radical prostatectomyMarco Bandini, Michele Marchioni, Raisa S Pompe, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 28, 2018
Racial disparities in lymph node dissection at radical prostatectomy: A Surveillance, Epidemiology and End Results database analysisFelix Preisser, Sebastiano Nazzani, Marco Bandini, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 29, 2022
UPDATE - Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategiesAndrea Kokorovic, Alan I So, Hosam Serag, et al.
Pageof 113